Published in Infect Immun on July 01, 1986
Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect Immun (2006) 1.17
Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infect Immun (1988) 1.13
In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins. Infect Immun (1990) 1.13
In vitro killing of oral Capnocytophaga by granule fractions of human neutrophils is associated with cathepsin G activity. J Clin Invest (1991) 1.01
Serum levels of antioxidants and superoxide dismutase in periodontitis patients with diabetes type 2. J Indian Soc Periodontol (2014) 1.00
Effect of ciprofloxacin on killing of Actinobacillus actinomycetemcomitans by polymorphonuclear leukocytes. Antimicrob Agents Chemother (2002) 0.94
Role of high-avidity binding of human neutrophil myeloperoxidase in the killing of Actinobacillus actinomycetemcomitans. Infect Immun (1987) 0.93
In vitro killing of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. by human neutrophil cathepsin G and elastase. Infect Immun (1991) 0.88
Killing of Actinobacillus actinomycetemcomitans by the human neutrophil myeloperoxidase-hydrogen peroxide-chloride system. Infect Immun (1986) 0.88
Effect of clindamycin on neutrophil killing of gram-negative periodontal bacteria. Antimicrob Agents Chemother (1988) 0.87
Functional properties of nonhuman primate antibody to Porphyromonas gingivalis. Infect Immun (1995) 0.87
Aggregatibacter actinomycetemcomitans, a potent immunoregulator of the periodontal host defense system and alveolar bone homeostasis. Mol Oral Microbiol (2015) 0.87
Differential killing of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. by human neutrophil granule components. Infect Immun (1991) 0.84
Opsonic antibody activity against Actinobacillus actinomycetemcomitans in patients with rapidly progressive periodontitis. Infect Immun (1992) 0.84
Antimicrobial peptides and nitric oxide production by neutrophils from periodontitis subjects. Braz J Med Biol Res (2012) 0.76
Comparative evaluation of effects of chlorhexidine and tetracycline on neutrophil viability and functions in vitro. J Indian Soc Periodontol (2012) 0.75
Gingival crevicular fluid and serum hCAP18/LL-37 levels in generalized aggressive periodontitis. Clin Oral Investig (2016) 0.75
Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest (1985) 8.63
Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol (1985) 5.85
Actinobacillus actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. Infect Immun (1980) 4.87
A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods (1980) 4.76
Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem (1978) 4.61
Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc (1972) 4.60
Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science (1970) 3.82
A bactericidal effect for human lactoferrin. Science (1977) 3.73
Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect Immun (1974) 3.49
Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes. J Lab Clin Med (1975) 3.24
Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease. Infect Immun (1983) 3.04
The predominant cultivable organisms in juvenile periodontitis. Scand J Dent Res (1976) 2.74
H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells. J Clin Invest (1977) 2.71
Characterization of the lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4 and N27. Infect Immun (1980) 2.34
Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B. Infect Immun (1984) 2.10
Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science (1983) 1.96
Impaired neutrophil chemotaxis in patients with juvenile and rapidly progressing periodontitis. J Periodontal Res (1979) 1.70
Collagenolytic activity associated with Bacteroides species and Actinobacillus actinomycetemcomitans. J Periodontal Res (1982) 1.69
Leukotoxic activity in different strains of the bacterium Actinobacillus actinomycetemcomitans isolated from juvenile periodontitis in man. Arch Oral Biol (1981) 1.64
Defective polymorphonuclear leukocyte function in a human periodontal disease. Nature (1977) 1.59
Oxidative peptide cleavage and decarboxylation by the MPO-H2O2-Cl- antimicrobial system. Infect Immun (1974) 1.58
Identification of tissue-invading bacteria in human periodontal disease. J Periodontal Res (1982) 1.54
Relationship between oxygen tension and subgingival bacterial flora in untreated human periodontal pockets. Infect Immun (1983) 1.54
Studies of leukotoxin from Actinobacillus actinomycetemcomitans using the promyelocytic HL-60 cell line. Infect Immun (1983) 1.53
Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein. Infect Immun (1976) 1.41
Immune suppression induced by Actinobacillus actinomycetemcomitans. I. Effects on human peripheral blood lymphocyte responses to mitogens and antigens. J Immunol (1982) 1.40
Outer membrane mutants of Salmonella typhimurium LT2 have lipopolysaccharide-dependent resistance to the bactericidal activity of anaerobic human neutrophils. Infect Immun (1982) 1.39
Defective neutrophil chemotaxis in juvenile periodontitis. Infect Immun (1977) 1.36
Enhanced killing of myeloperoxidase-coated bacteria in the myeloperoxidase-H2O2-Cl- system. J Infect Dis (1978) 1.32
N-(2-Oxoacyl)amino acids and nitriles as final products of dipeptide chlorination mediated by the myeloperoxidase/H2O2/Cl- system. Eur J Biochem (1978) 1.21
Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol (1983) 1.16
Bactericidal effect of pooled human serum on Bacteroides melaninogenicus, Bacteroides asaccharolyticus and Actinobacillus actinomycetemcomitans. Scand J Dent Res (1982) 1.14
Leukotoxic effects of Actinobacillus actinomycetemcomitans. Modulation by serum components. J Periodontal Res (1981) 1.12
The killing of pathogens by phagocytes. Annu Rev Med (1981) 1.00
Gingivitis and oral ulceration in patients with neutrophil dysfunction. J Oral Pathol (1985) 0.95
Resistance of Actinobacillus actinomycetemcomitans and differential susceptibility of oral Haemophilus species to the bactericidal effects of hydrogen peroxide. Infect Immun (1984) 0.93
Anaerobic phagocytosis, killing, and degradation of Streptococcus pneumoniae by human peripheral blood leukocytes. Infect Immun (1985) 0.88
Killing of Actinobacillus actinomycetemcomitans by the human neutrophil myeloperoxidase-hydrogen peroxide-chloride system. Infect Immun (1986) 0.88
Influence of endogenous catalase activity on the sensitivity of the oral bacterium Actinobacillus actinomycetemcomitans and the oral haemophili to the bactericidal properties of hydrogen peroxide. Arch Oral Biol (1985) 0.87
Phagocytic cells in periodontal defense. Periodontal status of patients with chronic granulomatous disease of childhood. J Periodontol (1985) 0.84
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA (1994) 14.96
Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res (2012) 5.57
Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction. J Dent Res (1984) 5.29
Actinobacillus actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. Infect Immun (1980) 4.87
Bacon therapy and furuncular myiasis. JAMA (1993) 4.79
The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics (1995) 4.72
Carbohydrate fermentation plate medium for confirmation of Neisseria species. J Clin Microbiol (1975) 3.89
Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. Arch Intern Med (2000) 3.82
A new medium for the isolation of pathogenic Neisseria (NYC medium). I. Formulation and comparisons with standard media. Health Lab Sci (1973) 3.66
Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight. Trans R Soc Trop Med Hyg (1983) 3.46
Identification of periodontal pathogens in atheromatous plaques. J Periodontol (2000) 3.45
Circulating concentrations of nocturnal leptin, growth hormone, and insulin-like growth factor-I increase before the onset of puberty in agonadal male monkeys: potential signals for the initiation of puberty. J Clin Endocrinol Metab (2000) 3.38
Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol (1994) 3.20
Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol (1998) 3.12
Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease. Infect Immun (1983) 3.04
Orotracheal intubation in patients with potential cervical spine injuries. An indication for the gum elastic bougie. Anaesthesia (1993) 2.98
Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol (2001) 2.97
Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun (2000) 2.95
Serum antibodies to oral Bacteroides asaccharolyticus (Bacteroides gingivalis): relationship to age and periondontal disease. Infect Immun (1981) 2.93
Predicting difficult intubation. Br J Anaesth (1993) 2.87
Isolation of Neisseria meningitidis from the Genito-urinary tract and anal canal. J Clin Microbiol (1975) 2.76
Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol (2000) 2.64
Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J Bacteriol (1994) 2.59
A new medium for the isolation of pathogenic Neisseria (NYC medium). II. Effect of amphotericin B and trimethoprim lactate on selectivity. Health Lab Sci (1973) 2.58
A survey of anaesthetic misadventures. Anaesthesia (1981) 2.40
Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol (1997) 2.39
Emergence of gentamicin- and methicillin-resistant Staphylococcus aureus strains in New York City hospitals. J Clin Microbiol (1981) 2.39
Inhibition of glucosyltransferase activity by antisera to known serotypes of Streptococcus mutans. Infect Immun (1973) 2.37
Evaluation of tuberculosis control policies using computer simulation. JAMA (1996) 2.32
Molecular cloning and sequencing of the gene encoding the fimbrial subunit protein of Bacteroides gingivalis. J Bacteriol (1988) 2.25
Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J Infect Dis (1990) 2.22
Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol (1991) 2.18
Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl Acad Sci U S A (2007) 2.15
Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol (1995) 2.15
Problems with the Mallampati sign. Anaesthesia (1990) 2.15
Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis (2000) 2.15
A randomized controlled trial of prenatal pediatric visits for urban, low-income families. Pediatrics (1996) 2.14
Heterogeneity of virulence among strains of Bacteroides gingivalis. J Periodontal Res (1989) 1.99
The selectivity of vancomycin and lincomycin in NYC medium for the recovery of N. gonorrhoeae from clinical specimens. Health Lab Sci (1978) 1.95
The need for global action against multidrug-resistant tuberculosis. JAMA (1999) 1.94
Human immune responses to oral micro-organisms. I. Association of localized juvenile periodontitis (LJP) with serum antibody responses to Actinobacillus actinomycetemcomitans. Clin Exp Immunol (1982) 1.93
Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci (1999) 1.90
Synthetic peptides analogous to the fimbrillin sequence inhibit adherence of Porphyromonas gingivalis. Infect Immun (1992) 1.90
Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol (1996) 1.90
Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol (2001) 1.90
Host responses in periodontal diseases. J Dent Res (1984) 1.90
Purification and properties of hemagglutinin from culture supernatant of Bacteroides gingivalis. Infect Immun (1986) 1.85
Direct hemagglutination technique for differentiating Bacteroides asaccharolyticus oral strains from nonoral strains. J Clin Microbiol (1979) 1.84
A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect Immun (1997) 1.84
Antigenic studies of oral and nonoral black-pigmented Bacteroides strains. Infect Immun (1980) 1.84
Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction. Infect Immun (1992) 1.82
Cloning, expression, and sequencing of a cell surface antigen containing a leucine-rich repeat motif from Bacteroides forsythus ATCC 43037. Infect Immun (1998) 1.79
Secretory gamma-A antibodies induced by local immunization. Nature (1969) 1.76
Prevention of Streptococcus mutans infection of tooth surfaces by salivary antibody in Irus monkeys (Macaca fascicularis). Infect Immun (1975) 1.74
Overcrowding and other crises: how can we survive? J Emerg Nurs (2001) 1.69
Self-reported measures for surveillance of periodontitis. J Dent Res (2013) 1.69
Pediatrician interview style and mothers' disclosure of psychosocial issues. Pediatrics (1994) 1.67
In-home injury prevention practices for infants and toddlers: the role of parental beliefs, barriers, and housing quality. Health Educ Q (1995) 1.67
Porphyromonas (Bacteroides) gingivalis fimbrillin: size, amino-terminal sequence, and antigenic heterogeneity. Infect Immun (1991) 1.67
Clinical criteria for the definition of "established periodontitis". J Periodontol (1992) 1.65
Unilateral intraocular lens implantation during the first six months of life. J AAPOS (1999) 1.64
The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol (2000) 1.63
Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis. I. Light, immunofluorescence and electron microscopic studies. J Periodontol (1987) 1.63
Characterization of tufted streptococci isolated from the "corn cob" configuration of human dental plaque. Infect Immun (1980) 1.63
Evidence for cyclic development and short-lived maturity in the gametocytes of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1971) 1.61
Defective polymorphonuclear leukocyte function in a human periodontal disease. Nature (1977) 1.59
Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc (1990) 1.59
Blastogenic response of human lymphocytes to oral bacterial antigens: comparison of individuals with periodontal disease to normal and edentulous subjects. Infect Immun (1976) 1.56
Spatial and temporal summation in impaired regions of the visual field. J Physiol (1967) 1.55
Purification, characterization and immunolocalization of fimbrial protein from Porphyromonas (bacteroides) gingivalis. Biochem Biophys Res Commun (1991) 1.54
Studies of leukotoxin from Actinobacillus actinomycetemcomitans using the promyelocytic HL-60 cell line. Infect Immun (1983) 1.53
Rupture of the anterior lens capsule in Alport syndrome. J AAPOS (1999) 1.53
Identification of Bacteroides gingivalis by fluorescent antibody staining. Ann Microbiol (Paris) (1982) 1.53
Randomized trial of enhanced anticipatory guidance for injury prevention. Arch Pediatr Adolesc Med (2001) 1.52
The role of osteopenia in oral bone loss and periodontal disease. J Periodontol (1996) 1.51
Actinobacillus actinomycetemcomitans in human periodontal disease. Association, serology, leukotoxicity, and treatment. J Periodontal Res (1982) 1.50
Projections from the lateral geniculate nucleus in the cat and monkey. J Anat (1967) 1.49
Location, transcription, and sequence of a baculovirus gene encoding a small arginine-rich polypeptide. J Virol (1987) 1.49
Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol (2000) 1.49
Osteoporosis and oral infection: independent risk factors for oral bone loss. J Dent Res (2008) 1.48
Relationship between social factors and pituitary-adrenocortical activity in female rhesus monkeys (Macaca mulatta). Horm Behav (1993) 1.48
Neutrophil chemotaxis dysfunction in human periodontitis. Infect Immun (1980) 1.48
Protection against gram-negative infections with antiserum to lipid A from Salmonella minnesota R595. Infect Immun (1974) 1.47
Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism. J Immunol (1986) 1.47
Surgery on the normal eye in Duane retraction syndrome. J Pediatr Ophthalmol Strabismus (1994) 1.46
Serum neutralizing activity against Actinobacillus actinomycetemcomitans leukotoxin in juvenile periodontitis. J Clin Periodontol (1981) 1.45
Social support and cancer screening in African American, Hispanic, and Native American women. Cancer Pract (1999) 1.44
Confirmation of confocal microscopy diagnosis of Acanthamoeba keratitis using polymerase chain reaction analysis. Arch Ophthalmol (2000) 1.44
Plasma immunoglobulin concentrations in an African (Gambian) community in relation to season, malaria and other infections and pregnancy. Clin Exp Immunol (1970) 1.43
Effects of temperature stress on expression of fimbriae and superoxide dismutase by Porphyromonas gingivalis. Infect Immun (1994) 1.42
Intraocular lenses for children in the year 2000: when is oversight by the institutional review board or food and drug administration required? J AAPOS (2000) 1.41
Structural and genetic analyses of O polysaccharide from Actinobacillus actinomycetemcomitans serotype f. Infect Immun (2001) 1.41
Emerging lessons of the Interdisciplinary Generalist Curriculum (IGC) Project. Acad Med (1998) 1.39
How safe is safe enough? New infections and the U.S. blood supply. Ann Intern Med (1992) 1.39
Surface thermodynamics of normal and pathological human granulocytes. Cell Biophys (1980) 1.38
Inhibition of neutrophil chemotaxis by soluble bacterial products. J Periodontol (1982) 1.38
Testing the radiochemical purity of technetium Tc 99m-labeled radiopharmaceuticals. Am J Health Syst Pharm (1995) 1.37
In vitro candidastatic properties of the human neutrophil calprotectin complex. J Immunol (1993) 1.37
Periodontal disease and NIDDM in Pima Indians. Diabetes Care (1990) 1.36